Navigation Links
Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology
Date:7/16/2009

INDIANAPOLIS and PERTH, Australia, July 16 /PRNewswire/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and NemGenix, a Perth based biotechnology company, announced today a newly established collaboration agreement to pursue novel technologies to produce nematode-resistant crops.

The collaboration will support a number of full-time researchers at NemGenix's facilities in Perth. Financial terms of the agreement were not disclosed.

"This exciting collaboration capitalizes on the strengths of both Dow AgroSciences and NemGenix to develop next-generation technology to help combat parasitic nematodes, which plague millions of crop acres across the globe," said Daniel R. Kittle, Ph.D., vice president of R&D for Dow AgroSciences. "Dow AgroSciences is continuously exploring and leveraging enabling technologies -- such as those from NemGenix -- to provide new crop protection solutions that benefit growers around the world."

Sean Hird, Ph.D., chief executive officer of NemGenix, said, "This multi-year collaboration is a key milestone in our corporate development and underscores our growing reputation as one of Australia's most exciting new biotechnology companies. Our research team is excited to have the opportunity to build on our expertise in nematode control with the strength and capabilities of a partner such as Dow AgroSciences."

About NemGenix

NemGenix is a privately held agricultural biotechnology company based at the Western Australia State Agricultural Biotechnology Centre in Perth. The company's focus is the research and development of new controls for plant parasitic nematodes. These endemic soil borne pathogens are estimated to cause $15bn of crop damage worldwide with losses of more than 15 percent in some crops, such as sugar cane. The company is currently funded by the Australian Government Department of Education, Science and Training to undertake the development of nematode resistant wheat. See www.nemgenix.com.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
2. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
3. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
5. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
6. Regado Biosciences Establishes Medical Advisory Board
7. DFG establishes 14 new research training groups
8. Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
9. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
10. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
11. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... Antonio, TX (PRWEB) , ... February 23, 2017 ... ... Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the ... indicated for adults at home or in healthcare facilities during periods of rest. ...
(Date:2/23/2017)... Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a ... conditions, today announced that Linda Marbán, Ph.D, president and chief ... conferences: Cowen and Company 37th Annual ... ET Boston, MA ... am PT (12:00 pm ET) Dana Point, CA ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology ... for research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
Breaking Biology News(10 mins):